N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide
C69H99N13O8SSi — CID 160516806
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide
N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide (PubChem CID 160516806) has the molecular formula C69H99N13O8SSi and a molecular weight of 1298.79 g/mol. Its IUPAC name is N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide.
Molecular Properties
| Compound Name | N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide |
|---|---|
| PubChem CID | 160516806 |
| Molecular Formula | C69H99N13O8SSi |
| Molecular Weight | 1298.79 g/mol |
| Exact Mass | 1297.72 |
| IUPAC Name | N-[1-[4-[tert-butyl(dimethyl)silyl]oxycyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;N-[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]-2-[(5-methyl-1,2-benzoxazol-3-yl)amino]acetamide;2-[(5-methyl-1,2-benzoxazol-3-yl)amino]-N-[1-(4-propan-2-ylcyclohexyl)azetidin-3-yl]acetamide |
| SMILES | Cc1ccc2onc(NCC(=O)NC3CN(C4CCC(C(C)C)CC4)C3)c2c1.Cc1ccc2onc(NCC(=O)NC3CN(C4CCC(O)(c5cncs5)CC4)C3)c2c1.Cc1ccc2onc(NCC(=O)NC3CN(C4CCC(O[Si](C)(C)C(C)(C)C)CC4)C3)c2c1 |
| InChI | InChI=1S/C25H40N4O3Si.C22H27N5O3S.C22H32N4O2/c1-17-7-12-22-21(13-17)24(28-31-22)26-14-23(30)27-18-15-29(16-18)19-8-10-20(11-9-19)32-33(5,6)25(2,3)4;1-14-2-3-18-17(8-14)21(26-30-18)24-10-20(28)25-15-11-27(12-15)16-4-6-22(29,7-5-16)19-9-23-13-31-19;1-14(2)16-5-7-18(8-6-16)26-12-17(13-26)24-21(27)11-23-22-19-10-15(3)4-9-20(19)28-25-22/h7,12-13,18-20H,8-11,14-16H2,1-6H3,(H,26,28)(H,27,30);2-3,8-9,13,15-16,29H,4-7,10-12H2,1H3,(H,24,26)(H,25,28);4,9-10,14,16-18H,5-8,11-13H2,1-3H3,(H,23,25)(H,24,27) |
| InChIKey | QTTMODRZTSVVJQ-UHFFFAOYSA-N |
| XLogP | 10.88 |
| TPSA | 253.55 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 92 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1298.79 |
| LogP ≤ 5 | 10.88 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160516806 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.